Lv4
480 积分 2021-11-01 加入
Efficacy and biomarker analysis of neoadjuvant disitamab vedotin (RC48‐ADC) combined immunotherapy in patients with muscle‐invasive bladder cancer: A multi‐center real‐world study
1个月前
已完结
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease
2个月前
已完结
Clinical Significance of Horizontal and Vertical Margin of En Bloc Resection for Nonmuscle Invasive Bladder Cancer
3个月前
已完结
Efficacy and safety of tislelizumab plus intravesical chemotherapy in recurrent high-risk non-muscle-invasive bladder cancer: A retrospective single-center real-world study
3个月前
已完结
The role of multiparametric MRI-based VI-RADS in predicting the need for a second TURB
3个月前
已完结
The role of multiparametric MRI-based VI-RADS in predicting the need for a second TURB
3个月前
已完结
Membrane palmitoylated protein MPP1 inhibits immune escape by regulating the USP12/ CCL5 axis in urothelial carcinoma
5个月前
已完结
Inhibition of SIRT4 promotes bladder cancer progression and immune escape via attenuating CD8+ T cells function
5个月前
已完结
Single-cell and spatial atlas unveil tumor-specific microenvironment convergence and a prognosis-associated PLXDC1+ myofibroblast population in metastatic bladder cancer
7个月前
已完结
Proxalutamide in metastatic castration‐resistant prostate cancer: Primary analysis of a multicenter, randomized, open‐label, phase 2 trial
8个月前
已完结
皖公网安备34019202002308
